This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Clinical
Spectrila® (asparaginase) by Medac received EU-wide approval for the treatment of ALL
Read more
Siemens Healthcare launches new assay range to improve workload consolidation in the laboratory
Read more
ESCMID experts gather data on the Zika virus: potential outbreaks in Africa and southern Europe
Read more
Axinesis obtains CE mark for REAplan, its medical interactive rehabilitation device
Read more
World Cancer Day 2016: COCIR raises importance of technologies
Read more
LC Bead LUMI™ Radiopaque Embolic Bead supported by Philips Live Image Guidance
Read more
EC approves Daklinza for the treatment of chronic hepatitis C patients
Read more
Illumigene® Malaria sets a new gold standard for diagnosis
Read more
Breakthrough drug for heart failure now available in the UK
Read more
Data shows effectiveness of biosimilar infliximab in patients with inflammatory bowel diseases
Read more
Sobi announces commercial launch of Elocta® in first countries in Europe
Read more
European Pain Federation EFIC® launches new information campaign
Read more
World’s first clinical guidelines for chronic fungal lung infections
Read more
Keytruda® significantly improves survival compared with chemotherapy in NSCLC
Read more
Launches give Roche the most comprehensive immunosuppressive drug monitoring portfolio
Read more
bene-Arzneimittel receives orphan drug status for pentosan polysulphate
Read more
UK company launches full range of pioneering pressure mattress solutions
Read more
Page 148 of 200
« First
«
...
10
20
30
...
146
147
148
149
150
...
160
170
180
...
»
Last »
Popular articles
Third of patients in favour of AI-supported consultations and clinical documents, study finds
18 April, 2024
Telemedicine strategy post-acute coronary syndrome drives efficiencies and safety, study finds
17 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
x
Search for: